6/8
08:49 am
flgt
What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing? [Yahoo! Finance]
Low
Report
What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing? [Yahoo! Finance]
6/3
08:00 am
flgt
Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
Low
Report
Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
5/24
08:12 am
flgt
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting [Yahoo! Finance]
Medium
Report
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting [Yahoo! Finance]
5/24
08:00 am
flgt
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
Medium
Report
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
5/15
05:24 am
flgt
Moffitt and Fulgent Pharma partner on personalised cancer therapies [Yahoo! Finance]
Low
Report
Moffitt and Fulgent Pharma partner on personalised cancer therapies [Yahoo! Finance]
5/14
04:16 pm
flgt
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics [Yahoo! Finance]
Low
Report
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics [Yahoo! Finance]
5/14
04:05 pm
flgt
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
Low
Report
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
5/14
09:08 am
flgt
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain [Yahoo! Finance]
Low
Report
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain [Yahoo! Finance]
5/14
09:00 am
flgt
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Low
Report
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
5/6
04:10 pm
flgt
Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Medium
Report
Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
5/4
09:33 am
flgt
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
09:56 am
flgt
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
5/3
07:11 am
flgt
Fulgent Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Fulgent Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/3
07:00 am
flgt
Fulgent Reports First Quarter 2024 Financial Results
Low
Report
Fulgent Reports First Quarter 2024 Financial Results
4/26
10:38 am
flgt
Global $5.4 Billion Carrier Screening Market, 2024-2028: Analysis by Product & Service, Type, Technology, Medical Condition, End-user, and Region [Yahoo! Finance]
Low
Report
Global $5.4 Billion Carrier Screening Market, 2024-2028: Analysis by Product & Service, Type, Technology, Medical Condition, End-user, and Region [Yahoo! Finance]
4/11
04:05 pm
flgt
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Low
Report
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
4/11
09:07 am
flgt
Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years [Yahoo! Finance]
Low
Report
Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years [Yahoo! Finance]